Candela gears up for ScleroLaser launch:
This article was originally published in Clinica
Candela plans to launch ScleroLaser later this quarter. The leg-vein treatment system has gone into production and will be launched at the American Academy of Dermatology annual meeting in Washington in February, along with recent clinical data. The FDA cleared the laser in April 1995 (see Clinica No 653, p19).
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.